Canada markets close in 3 hours 46 minutes

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.5100-0.1700 (-6.34%)
As of 12:14PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 685.79M
Enterprise Value 214.65M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)9.97k
Price/Book (mrq)1.14
Enterprise Value/Revenue 3.16k
Enterprise Value/EBITDA 0.35

Trading Information

Stock Price History

Beta (5Y Monthly) -0.55
52-Week Change 36.35%
S&P500 52-Week Change 326.43%
52 Week High 33.9700
52 Week Low 31.3200
50-Day Moving Average 32.3314
200-Day Moving Average 32.0642

Share Statistics

Avg Vol (3 month) 3902.97k
Avg Vol (10 day) 3703.02k
Shares Outstanding 5254.94M
Implied Shares Outstanding 6254.94M
Float 8164.19M
% Held by Insiders 115.40%
% Held by Institutions 172.51%
Shares Short (Apr 15, 2024) 418.23M
Short Ratio (Apr 15, 2024) 418.38
Short % of Float (Apr 15, 2024) 410.17%
Short % of Shares Outstanding (Apr 15, 2024) 47.15%
Shares Short (prior month Mar 15, 2024) 410.38M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,853,000.00%

Management Effectiveness

Return on Assets (ttm)-18.93%
Return on Equity (ttm)-32.93%

Income Statement

Revenue (ttm)68k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-95.40%
Gross Profit (ttm)N/A
EBITDA -218.29M
Net Income Avi to Common (ttm)-228.34M
Diluted EPS (ttm)-0.9000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)526.3M
Total Cash Per Share (mrq)2.06
Total Debt (mrq)61.83M
Total Debt/Equity (mrq)10.25%
Current Ratio (mrq)16.51
Book Value Per Share (mrq)2.37

Cash Flow Statement

Operating Cash Flow (ttm)-159.5M
Levered Free Cash Flow (ttm)-84.2M